Able 0 4 0 4 O
to 5 7 5 7 O
receive 8 15 8 15 O
the 16 19 16 19 O
first 20 25 20 25 O
dose 26 30 26 30 O
of 31 33 31 33 O
rivipansel 34 44 34 44 B-treatment
within 45 51 45 51 O
24 52 54 52 54 B-upper_bound
hours 55 60 55 60 I-upper_bound
from 61 65 61 65 O
administration 66 80 66 80 O
of 81 83 81 83 O
the 84 87 84 87 O
first 88 93 88 93 O
dose 94 98 94 98 O
of 99 101 99 101 O
IV 102 104 102 104 B-treatment
opioids 105 112 105 112 I-treatment
for 113 116 113 116 O
this 117 121 117 121 O
hospitalization 122 137 122 137 O

At 0 2 138 140 O
least 3 8 141 146 O
6 9 10 147 148 B-lower_bound
years 11 16 149 154 I-lower_bound
of 17 19 155 157 O
age 20 23 158 161 B-age

Completion 0 10 162 172 O
of 11 13 173 175 O
Study 14 19 176 181 B-treatment
B5201002 20 28 182 190 I-treatment

Diagnosis 0 9 191 200 O
of 10 12 201 203 O
VOC 13 16 204 207 O
necessitating 17 30 208 221 O
IV 31 33 222 224 B-treatment
opioids 34 41 225 232 I-treatment
and 42 45 233 236 O
admission 46 55 237 246 O
to 56 58 247 249 O
the 59 62 250 253 O
hospital 63 71 254 262 O

Documented 0 10 263 273 O
diagnosis 11 20 274 283 O
of 21 23 284 286 O
SCD 24 27 287 290 B-chronic_disease

Male 0 4 291 295 B-gender
and 5 8 296 299 I-gender
female 9 15 300 306 I-gender
subjects 16 24 307 315 I-gender
of 25 27 316 318 O
childbearing 28 40 319 331 O
potential 41 50 332 341 O
and 51 54 342 345 O
at 55 57 346 348 O
risk 58 62 349 353 O
for 63 66 354 357 O
pregnancy 67 76 358 367 B-pregnancy
must 77 81 368 372 O
agree 82 87 373 378 B-contraception_consent
to 88 90 379 381 I-contraception_consent
use 91 94 382 385 I-contraception_consent
a 95 96 386 387 I-contraception_consent
highly 97 103 388 394 I-contraception_consent
effective 104 113 395 404 I-contraception_consent
method 114 120 405 411 I-contraception_consent
of 121 123 412 414 I-contraception_consent
contraception 124 137 415 428 I-contraception_consent
throughout 138 148 429 439 O
the 149 152 440 443 O
study 153 158 444 449 O

Occurrence 0 10 450 460 O
of 11 13 461 463 O
any 14 17 464 467 O
severe 18 24 468 474 O
and/or 25 31 475 481 O
generalized 32 43 482 493 O
cutaneous 44 53 494 503 B-chronic_disease
manifestation 54 67 504 517 I-chronic_disease
or 68 70 518 520 O
any 71 74 521 524 O
other 75 80 525 530 O
adverse 81 88 531 538 O
event 89 94 539 544 O
during 95 101 545 551 O
participation 102 115 552 565 O
in 116 118 566 568 O
Study 119 124 569 574 B-treatment
B5201002 125 133 575 583 I-treatment
that 134 138 584 588 O
was 139 142 589 592 O
related 143 150 593 600 O
to 151 153 601 603 O
study 154 159 604 609 B-treatment
drug 160 164 610 614 I-treatment
and 165 168 615 618 O
which 169 174 619 624 O
would 175 180 625 630 O
therefore 181 190 631 640 O
make 191 195 641 645 O
it 196 198 646 648 O
inappropriate 199 212 649 662 O
for 213 216 663 666 O
the 217 220 667 670 O
subject 221 228 671 678 O
to 229 231 679 681 O
receive 232 239 682 689 O
rivipansel 240 250 690 700 B-treatment
in 251 253 701 703 O
the 254 257 704 707 O
current 258 265 708 715 O
study 266 271 716 721 O

Other 0 5 722 727 O
severe 6 12 728 734 O
acute 13 18 735 740 O
or 19 21 741 743 O
chronic 22 29 744 751 O
medical 30 37 752 759 B-chronic_disease
or 38 40 760 762 I-chronic_disease
psychiatric 41 52 763 774 I-chronic_disease
condition 53 62 775 784 I-chronic_disease
or 63 65 785 787 O
laboratory 66 76 788 798 O
abnormality 77 88 799 810 O
that 89 93 811 815 O
may 94 97 816 819 O
increase 98 106 820 828 O
the 107 110 829 832 O
risk 111 115 833 837 O
associated 116 126 838 848 O
with 127 131 849 853 O
study 132 137 854 859 O
participation 138 151 860 873 O
or 152 154 874 876 O
study 155 160 877 882 B-treatment
drug 161 165 883 887 I-treatment
administration 166 180 888 902 O
or 181 183 903 905 O
may 184 187 906 909 O
interfere 188 197 910 919 O
with 198 202 920 924 O
the 203 206 925 928 O
interpretation 207 221 929 943 O
of 222 224 944 946 O
study 225 230 947 952 O
results 231 238 953 960 O

Pregnant 0 8 961 969 B-pregnancy
female 9 15 970 976 B-gender
subjects 16 24 977 985 I-gender

breastfeeding 0 13 986 999 O
female 14 20 1000 1006 B-gender
subjects 21 29 1007 1015 I-gender

male 0 4 1016 1020 B-gender
and 5 8 1021 1024 O
female 9 15 1025 1031 B-gender
subjects 16 24 1032 1040 I-gender
of 25 27 1041 1043 O
childbearing 28 40 1044 1056 O
potential 41 50 1057 1066 O
who 51 54 1067 1070 O
are 55 58 1071 1074 O
unwilling 59 68 1075 1084 B-contraception_consent
or 69 71 1085 1087 I-contraception_consent
unable 72 78 1088 1094 I-contraception_consent
to 79 81 1095 1097 I-contraception_consent
use 82 85 1098 1101 I-contraception_consent
a 86 87 1102 1103 I-contraception_consent
highly 88 94 1104 1110 I-contraception_consent
effective 95 104 1111 1120 I-contraception_consent
method 105 111 1121 1127 I-contraception_consent
of 112 114 1128 1130 I-contraception_consent
contraception 115 128 1131 1144 I-contraception_consent

